BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu T, Wang M, Jiang L, Ma L, Wan L, Chen Q, Wei C, Wang Z. CircRNAs in anticancer drug resistance: recent advances and future potential. Mol Cancer 2020;19:127. [PMID: 32799866 DOI: 10.1186/s12943-020-01240-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Tang X, Ren H, Guo M, Qian J, Yang Y, Gu C. Review on circular RNAs and new insights into their roles in cancer. Comput Struct Biotechnol J 2021;19:910-28. [PMID: 33598105 DOI: 10.1016/j.csbj.2021.01.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
2 Wang L, Weng W, Yang S, Yang S, Du R. Circle RNA circ_0007331 promotes colorectal carcinoma by targeting miR-205-5p/high-mobility group A2 axis. Bioengineered 2022;13:9312-21. [DOI: 10.1080/21655979.2022.2051857] [Reference Citation Analysis]
3 Xi SJ, Cai WQ, Wang QQ, Peng XC. Role of circular RNAs in gastrointestinal tumors and drug resistance. World J Clin Cases 2021; 9(34): 10400-10417 [PMID: 35004973 DOI: 10.12998/wjcc.v9.i34.10400] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Jin M, Zhang F, Li Q, Xu R, Liu Y, Zhang Y. Circ_0011292 knockdown mitigates progression and drug resistance in PTX-resistant non-small-cell lung cancer cells by regulating miR-433-3p/CHEK1 axis. Thorac Cancer 2022. [PMID: 35348291 DOI: 10.1111/1759-7714.14378] [Reference Citation Analysis]
5 Chen J, Wu S, Wang J, Sha Y, Ji Y. Hsa_circ_0074269-mediated Upregulation of TUFT1 Through miR-485-5p Increases Cisplatin Resistance in Cervical Cancer. Reprod Sci 2022. [PMID: 35075616 DOI: 10.1007/s43032-022-00855-9] [Reference Citation Analysis]
6 Huang L, Ma J, Cui M. Circular RNA hsa_circ_0001598 promotes programmed death-ligand-1-mediated immune escape and trastuzumab resistance via sponging miR-1184 in breast cancer cells. Immunol Res 2021;69:558-67. [PMID: 34559381 DOI: 10.1007/s12026-021-09237-w] [Reference Citation Analysis]
7 Liu L, Zhang P, Dong X, Li H, Li S, Cheng S, Yuan J, Yang X, Qian Z, Dong J. Circ_0001367 inhibits glioma proliferation, migration and invasion by sponging miR-431 and thus regulating NRXN3. Cell Death Dis 2021;12:536. [PMID: 34035217 DOI: 10.1038/s41419-021-03834-1] [Reference Citation Analysis]
8 Micallef I, Baron B. The Mechanistic Roles of ncRNAs in Promoting and Supporting Chemoresistance of Colorectal Cancer. Noncoding RNA 2021;7:24. [PMID: 33807355 DOI: 10.3390/ncrna7020024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
9 De Palma FDE, Salvatore F, Pol JG, Kroemer G, Maiuri MC. Circular RNAs as Potential Biomarkers in Breast Cancer. Biomedicines 2022;10:725. [PMID: 35327527 DOI: 10.3390/biomedicines10030725] [Reference Citation Analysis]
10 Cao Y, Xie X, Li M, Gao Y. CircHIPK2 Contributes to DDP Resistance and Malignant Behaviors of DDP-Resistant Ovarian Cancer Cells Both in vitro and in vivo Through circHIPK2/miR-338-3p/CHTOP ceRNA Pathway. Onco Targets Ther 2021;14:3151-65. [PMID: 34012271 DOI: 10.2147/OTT.S291823] [Reference Citation Analysis]
11 Chu D, Li P, Li Y, Shi J, Huang S, Jiao P. Identification of circ_0058357 as a regulator in non-small cell lung cancer cells resistant to cisplatin by miR-361-3p/ABCC1 axis. Thorac Cancer 2021;12:2894-906. [PMID: 34523261 DOI: 10.1111/1759-7714.14150] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Wu X, Wu J, Wang L, Yang W, Wang B, Yang H. CircRNAs in Malignant Tumor Radiation: The New Frontier as Radiotherapy Biomarkers. Front Oncol 2022;12:854678. [PMID: 35372031 DOI: 10.3389/fonc.2022.854678] [Reference Citation Analysis]
13 Wang Y, Zhou XY, Lu XY, Chen KD, Yao HP. Involvement of the circular RNA/microRNA/glucose-6-phosphate dehydrogenase axis in the pathological mechanism of hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2021:S1499-3872(21)00170-3. [PMID: 34548225 DOI: 10.1016/j.hbpd.2021.08.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
14 Khan FA, Nsengimana B, Khan NH, Song Z, Ngowi EE, Wang Y, Zhang W, Ji S. Chimeric Peptides/Proteins Encoded by circRNA: An Update on Mechanisms and Functions in Human Cancers. Front Oncol 2022;12:781270. [DOI: 10.3389/fonc.2022.781270] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
15 Sun W, Zhou H, Han X, Hou L, Xue X. Circular RNA: A novel type of biomarker for glioma (Review). Mol Med Rep 2021;24:602. [PMID: 34165178 DOI: 10.3892/mmr.2021.12240] [Reference Citation Analysis]
16 Wang H, Meng Q, Qian J, Li M, Gu C, Yang Y. Review: RNA-based diagnostic markers discovery and therapeutic targets development in cancer. Pharmacol Ther 2022;234:108123. [PMID: 35121000 DOI: 10.1016/j.pharmthera.2022.108123] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
17 Tan L, Huang Z, Chen Z, Chen S, Ye Y, Chen T, Chen Z. CircRNA_001895 promotes sunitinib resistance of renal cell carcinoma through regulation of apoptosis and DNA damage repair. J Chemother 2021;:1-8. [PMID: 34927575 DOI: 10.1080/1120009X.2021.2009990] [Reference Citation Analysis]
18 Wang W, Xie S, Yuan D, He D, Fang L, Ge F. Systematic Review With Meta-Analysis: Diagnostic, Prognostic and Clinicopathological Significance of CircRNA Expression in Renal Cancer. Front Oncol 2022;11:773236. [DOI: 10.3389/fonc.2021.773236] [Reference Citation Analysis]
19 Chen C, Guo Y, Guo Y, Wu X, Si C, Xu Y, Kang Q, Sun Z. m6A Modification in Non-Coding RNA: The Role in Cancer Drug Resistance. Front Oncol 2021;11:746789. [PMID: 34745970 DOI: 10.3389/fonc.2021.746789] [Reference Citation Analysis]
20 Al Safi MA, Rashid HM, Afifi FU, Talib WH. Gaz Alafi: A Traditional Dessert in the Middle East With Anticancer, Immunomodulatory, and Antimicrobial Activities. Front Nutr 2022;9:900506. [DOI: 10.3389/fnut.2022.900506] [Reference Citation Analysis]
21 Sun K, Wang D, Yang BB, Ma J. The Emerging Functions of Circular RNAs in Bladder Cancer. Cancers (Basel) 2021;13:4618. [PMID: 34572845 DOI: 10.3390/cancers13184618] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Li P, Chen J, Zou J, Zhu W, Zang Y, Li H. Circular RNA coiled-coil domain containing 66 regulates malignant development of papillary thyroid carcinoma by upregulating La ribonucleoprotein 1 via the sponge effect on miR-129-5p. Bioengineered 2022;13:7181-96. [PMID: 35264065 DOI: 10.1080/21655979.2022.2036304] [Reference Citation Analysis]
23 Dai C, Ma Z, Si J, An G, Zhang W, Li S, Ma Y. Hsa_circ_0007312 Promotes Third-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Resistance through Pyroptosis and Apoptosis via the MiR-764/MAPK1 Axis in Lung Adenocarcinoma Cells. J Cancer 2022;13:2798-809. [PMID: 35812182 DOI: 10.7150/jca.72066] [Reference Citation Analysis]
24 Li W, Liu JQ, Chen M, Xu J, Zhu D. Circular RNA in cancer development and immune regulation. J Cell Mol Med 2020. [PMID: 33277969 DOI: 10.1111/jcmm.16102] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
25 Wang S, Qian L, Cao T, Xu L, Jin Y, Hu H, Fu Q, Li Q, Wang Y, Wang J, Xia Y, Huang X. Advances in the Study of CircRNAs in Tumor Drug Resistance. Front Oncol 2022;12:868363. [DOI: 10.3389/fonc.2022.868363] [Reference Citation Analysis]
26 Xie W, Chu M, Song G, Zuo Z, Han Z, Chen C, Li Y, Wang ZW. Emerging roles of long noncoding RNAs in chemoresistance of pancreatic cancer. Semin Cancer Biol 2020:S1044-579X(20)30222-4. [PMID: 33207266 DOI: 10.1016/j.semcancer.2020.11.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
27 Wassel MMS, Ammar YA, Elhag Ali GAM, Belal A, Mehany ABM, Ragab A. Development of adamantane scaffold containing 1,3,4-thiadiazole derivatives: Design, synthesis, anti-proliferative activity and molecular docking study targeting EGFR. Bioorg Chem 2021;110:104794. [PMID: 33735711 DOI: 10.1016/j.bioorg.2021.104794] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
28 Yang X, Zhang Q, Guan B. Circ_0110805 Knockdown Enhances Cisplatin Sensitivity and Inhibits Gastric Cancer Progression by miR-299-3p/ENDOPDI Axis. Onco Targets Ther 2020;13:11445-57. [PMID: 33192077 DOI: 10.2147/OTT.S279563] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
29 Shi R, Zhang W, Zhang J, Yu Z, An L, Zhao R, Zhou X, Wang Z, Wei S, Wang H. CircESRP1 enhances metastasis and epithelial-mesenchymal transition in endometrial cancer via the miR-874-3p/CPEB4 axis. J Transl Med 2022;20:139. [PMID: 35317822 DOI: 10.1186/s12967-022-03334-6] [Reference Citation Analysis]
30 Ying H, Zhao R, Yu Q, Zhang K, Deng Q. CircATL2 enhances paclitaxel resistance of ovarian cancer via impacting miR-506-3p/NFIB axis. Drug Dev Res 2021. [PMID: 34541682 DOI: 10.1002/ddr.21882] [Reference Citation Analysis]
31 Chao F, Wang S, Zhang C, Han D, Xu G, Chen G. The Emerging Role of Circular RNAs in Prostate Cancer: A Systematic Review. Front Cell Dev Biol 2021;9:681163. [PMID: 34386491 DOI: 10.3389/fcell.2021.681163] [Reference Citation Analysis]
32 Liu D, Jia H, Lu J, Zou X, Qian T, Peng F, Cao G, Wang M, Liu S. Expression of CircATXN7 in esophageal cancer tissues and its effect on cell proliferation and invasion. J Gastrointest Oncol 2022;13:912-22. [PMID: 35837168 DOI: 10.21037/jgo-22-481] [Reference Citation Analysis]
33 Gao H, Hu Z, Zhang X. Circular RNA hsa_circ_0057452 facilitates keloid progression by targeting the microRNA-1225-3p/AF4/FMR2 family member 4 axis. Bioengineered 2022;13:13815-28. [PMID: 35706403 DOI: 10.1080/21655979.2022.2084460] [Reference Citation Analysis]
34 Du S, Li H, Lu F, Zhang S, Tang J. Circular RNA ZNF609 promotes the malignant progression of glioma by regulating miR-1224-3p/PLK1 signaling. J Cancer 2021;12:3354-66. [PMID: 33976745 DOI: 10.7150/jca.54934] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
35 Gao Y, Huang Y. Circ_0007841 knockdown confers cisplatin sensitivity to ovarian cancer cells by down-regulation of NFIB expression in a miR-532-5p-dependent manner. J Chemother 2022;:1-14. [PMID: 35380509 DOI: 10.1080/1120009X.2022.2056995] [Reference Citation Analysis]
36 Lv W, Liu S, Zhang Q, Hu W, Wu Y, Ren Y. Circular RNA CircCOL5A1 Sponges the MiR-7-5p/Epac1 Axis to Promote the Progression of Keloids Through Regulating PI3K/Akt Signaling Pathway. Front Cell Dev Biol 2021;9:626027. [PMID: 33553184 DOI: 10.3389/fcell.2021.626027] [Reference Citation Analysis]
37 Feng D, Lv J, Li K, Cao Q, Han J, Yu H, Cheng Y, Zhuang J, Cai L, Yang H, Yang X, Lu Q. CircZNF609 promotes bladder cancer progression and inhibits cisplatin sensitivity via miR-1200/CDC25B pathway. Cell Biol Toxicol 2022. [PMID: 35567596 DOI: 10.1007/s10565-022-09715-3] [Reference Citation Analysis]
38 Lin Z, Xie X, Lu S, Liu T. Noncoding RNAs in osteosarcoma: Implications for drug resistance. Cancer Lett 2021;504:91-103. [PMID: 33587978 DOI: 10.1016/j.canlet.2021.02.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
39 Fang L, Lv J, Xuan Z, Li B, Li Z, He Z, Li F, Xu J, Wang S, Xia Y, Jiang T, Zhang L, Wang L, Zhang D, Xu H, Yang L, Xu Z, Wang W. Circular CPM promotes chemoresistance of gastric cancer via activating PRKAA2‐mediated autophagy. Clinical & Translational Med 2022;12. [DOI: 10.1002/ctm2.708] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Chang Z, Fu Y, Jia Y, Gao M, Song L, Zhang W, Zhao R, Qin Y. Circ-SFMBT2 drives the malignant phenotypes of esophageal cancer by the miR-107-dependent regulation of SLC1A5. Cancer Cell Int 2021;21:495. [PMID: 34530825 DOI: 10.1186/s12935-021-02156-8] [Reference Citation Analysis]
41 Lu HJ, Li J, Yang G, Yi CJ, Zhang D, Yu F, Ma Z. Circular RNAs in stem cells: from basic research to clinical implications. Biosci Rep 2022;42:BSR20212510. [PMID: 34908111 DOI: 10.1042/BSR20212510] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]